16:19 EST PTC Therapeutics (PTCT) sees 2024 revenue $750M-$800M, consensus $734.43M
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTCT:
- PTC Therapeutics announces FDA acceptance of Translarna NDA resubmission
- PTC Therapeutics (PTCT) Q3 Earnings Cheat Sheet
- PTC Therapeutics Faces Setback on Translarna Approval
- Catalyst Pharmaceuticals price target raised to $27 from $26 at BofA
- PTC Therapeutics announces negative CHMP opinion on Translarna authorization